Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesco Lo-Coco

Showing results (51-60 of 265) with videos related to

Pageof 27
Sort By:
Current Opinion in Oncology|October 1, 2013
Biology and management of therapy-related acute promyelocytic leukemiaFrancesco Lo-Coco, Syed K Hasan, Pau Montesinos, et al.
Blood Cells, Molecules & Diseases|September 29, 2017
Mechanisms of anti-cancer effects of ascorbate: Cytotoxic activity and epigenetic modulationDomenico Mastrangelo, Elvira Pelosi, Germana Castelli, et al.
Seminars in Hematology|May 16, 2002
Molecular monitoring of hematologic malignancies: current and future issuesFrancesco Lo Coco, Silvia De Santis, Anna Esposito, et al.
Mediterranean Journal of Hematology and Infectious Diseases|May 8, 2014
Acute Promyelocytic Leukemia (APL): Comparison Between Children and AdultsAnna Maria Testi, Mariella D'Angiò, Franco Locatelli, et al.
Biochemical Pharmacology|April 28, 2019
Targeting ADP-ribosylation by PARP inhibitors in acute myeloid leukaemia and related disordersIsabella Faraoni, Manuela Giansanti, Maria Teresa Voso, et al.
Leukemia|January 13, 2019
Prof. Franco Mandelli Leukaemia Visionary. May 12, 1931- July 15, 2018Sergio Amadori, William Arcese, Giuseppe Avvisati, et al.
British Journal of Haematology|June 24, 2009
Successful pregnancy after arsenic trioxide therapy for relapsed acute promyelocytic leukaemiaEmanuele Ammatuna, Annafranca Cavaliere, Mariadomenica Divona, et al.
Haematologica|June 11, 2011
Efficacy of prolonged therapy with combined arsenic trioxide and ATRA for relapse of acute promyelocytic leukemiaMassimo Breccia, Laura Cicconi, Clara Minotti, et al.
Journal of Hematology & Oncology|June 12, 2012
MiR-424 and miR-155 deregulated expression in cytogenetically normal acute myeloid leukaemia: correlation with NPM1 and FLT3 mutation statusIsabella Faraoni, Serena Laterza, Davide Ardiri, et al.
British Journal of Haematology|February 22, 2011
Immunophenotypic features of acute myeloid leukaemia patients exhibiting high FLT3 expression not associated with mutationsRoberta Riccioni, Elvira Pelosi, Viviana Riti, et al.
Pageof 27

Showing results (51-60 of 265) with videos related to

Sort By:
Pageof 27
Current Opinion in Oncology|October 1, 2013
Biology and management of therapy-related acute promyelocytic leukemiaFrancesco Lo-Coco, Syed K Hasan, Pau Montesinos, et al.
Blood Cells, Molecules & Diseases|September 29, 2017
Mechanisms of anti-cancer effects of ascorbate: Cytotoxic activity and epigenetic modulationDomenico Mastrangelo, Elvira Pelosi, Germana Castelli, et al.
Seminars in Hematology|May 16, 2002
Molecular monitoring of hematologic malignancies: current and future issuesFrancesco Lo Coco, Silvia De Santis, Anna Esposito, et al.
Mediterranean Journal of Hematology and Infectious Diseases|May 8, 2014
Acute Promyelocytic Leukemia (APL): Comparison Between Children and AdultsAnna Maria Testi, Mariella D'Angiò, Franco Locatelli, et al.
Biochemical Pharmacology|April 28, 2019
Targeting ADP-ribosylation by PARP inhibitors in acute myeloid leukaemia and related disordersIsabella Faraoni, Manuela Giansanti, Maria Teresa Voso, et al.
Leukemia|January 13, 2019
Prof. Franco Mandelli Leukaemia Visionary. May 12, 1931- July 15, 2018Sergio Amadori, William Arcese, Giuseppe Avvisati, et al.
British Journal of Haematology|June 24, 2009
Successful pregnancy after arsenic trioxide therapy for relapsed acute promyelocytic leukaemiaEmanuele Ammatuna, Annafranca Cavaliere, Mariadomenica Divona, et al.
Haematologica|June 11, 2011
Efficacy of prolonged therapy with combined arsenic trioxide and ATRA for relapse of acute promyelocytic leukemiaMassimo Breccia, Laura Cicconi, Clara Minotti, et al.
Journal of Hematology & Oncology|June 12, 2012
MiR-424 and miR-155 deregulated expression in cytogenetically normal acute myeloid leukaemia: correlation with NPM1 and FLT3 mutation statusIsabella Faraoni, Serena Laterza, Davide Ardiri, et al.
British Journal of Haematology|February 22, 2011
Immunophenotypic features of acute myeloid leukaemia patients exhibiting high FLT3 expression not associated with mutationsRoberta Riccioni, Elvira Pelosi, Viviana Riti, et al.
Pageof 27